Validation of "Lung Age" Measured by Spirometry and Handy Electronic FEV1/FEV6 Meter in Pulmonary Diseases
スポンサーリンク
概要
- 論文の詳細を見る
Objective The concept of "lung age" is thought to be useful for understanding pulmonary function. In this study, we validated "lung age" to detect pulmonary function abnormalities in pulmonary diseases. Methods We used both spirometry and an electronic FEV1/FEV6 meter (FEV6 meter) to perform pulmonary function tests. We evaluated the sensitivity and specificity of FEV6 and FEV1/FEV6, and calculated "lung age" in Japanese subjects including those with chronic obstructive pulmonary disease (COPD), bronchial asthma (BA), and interstitial lung diseases (ILD). Results FEV1 (spirometer) vs. FEV1 (FEV6 meter), FVC (spirometer) vs. FEV6 (FEV6 meter), and FEV1/FVC (spirometer) vs. FEV1/FEV6 (FEV6 meter) measurements were all significantly and closely correlated. For the difference of "lung age" and "actual age", the area under the receiver operating characteristic curve (ROC-AUC) for detecting obstructive impairment was 0.807 (spirometer) and 0.772 (FEV6 meter), respectively. The corresponding ROC-AUC for detecting restrictive impairment was 0.891 and 0.836, respectively, and that for detecting both obstructive and restrictive impairment was 0.918 and 0.853, respectively. For detection of both obstructive and restrictive impairment, the difference of the "lung age" and "actual age" cut-off value, corresponding to the greatest sum of sensitivity and specificity, was 18.3 years (spirometer) and 19.8 years (FEV6 meter), respectively. The sensitivity was 0.783 (spirometer) and 0.801 (FEV6 meter), and the specificity was 0.895 (spirometer) and 0.790 (FEV6 meter), respectively. Conclusion "Lung age" can provide an easy interpretation of the results, and can detect pulmonary function abnormalities in pulmonary diseases.
著者
-
Aizawa Hisamichi
Division Of Respirology Neurology And Rheumatology Department Of Internal Medicine Kurume University
-
Hoshino Tomoaki
Division Of Respirology Neurology And Rheumatology Department Of Internal Medicine Kurume University
-
Sakazaki Yuki
Division Of Respirology Neurology And Rheumatology Department Of Medicine Kurume University School O
-
Imaoka Haruki
Division Of Respirology Neurology And Rheumatology Department Of Medicine Kurume University School O
-
Toda Reiko
Division Of Respirology Neurology And Rheumatology Department Of Medicine Kurume University School O
-
KAWAYAMA TOMOTAKA
Division of Respiratory Medicine, Social Insurance Tagawa Hospital
-
Kinoshita Masaharu
Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine
-
Iwanaga Tomoaki
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine
-
Tsuda Toru
Department of Medicine, Kirigaoka Tsuda Hospital
-
Takada Shohei
Division of Respirology, Department of Medicine, National Hospital Organization Fukuoka-Higashi Medical Center
-
Sakazaki Yuki
Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine
関連論文
- Clearance of Inhaled Potassium Octatitanate Whisker from Rat Lungs
- Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus
- Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
- Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
- Elevated Levels of Thioredoxin 1 in the Lungs and Sera of Idiopathic Pulmonary Fibrosis, Non-Specific Interstitial Pneumonia and Cryptogenic Organizing Pneumonia
- Endogenous and Exogenous Thioredoxin 1 Prevents Goblet Cell Hyperplasia in a Chronic Antigen Exposure Asthma Model
- Efficacy and Safety of Formoterol in Japanese Patients with COPD
- Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
- High Plasma Brain Natriuretic Peptide Levels in Stable COPD without Pulmonary Hypertension or Cor Pulmonale
- Twelve-year Cumulative Incidence of Airflow Obstruction among Japanese Males
- Pharmacological Treatment in Asthma and COPD
- Validation of "Lung Age" Measured by Spirometry and Handy Electronic FEV1/FEV6 Meter in Pulmonary Diseases
- C-reactive protein levels, airflow obstruction, and chronic kidney disease
- Factors that Impact Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease
- Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline
- Successful Treatment with Tacrolimus in a Case of Lung-dominant Connective Tissue Disease
- Addison's Disease Induced by Miliary Tuberculosis and the Administration of Rifampicin
- Correlation of Decreased Survival and IL-18 in Bone Metastasis
- Clinical Study of Severe Influenza Virus Pneumonia That Caused Acute Respiratory Failure.